Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global PI Market Portraiture
2.2. Global PI Market, by Product, 2018 (US$ Mn)
2.3. Global PI Market, by End User, 2018 (US$ Mn)
2.4. Global PI Market, by Geography, 2018 (US$ Mn)
Chapter 3. Pharmaceutical Intermediates (PI) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global PI Market, by Key Players, 2018
Chapter 4. Global Pharmaceutical Intermediates (PI) Market, by Product
4.1. Overview
4.2. Bulk Drug Intermediates
4.3. Chemical Intermediates
4.4. Custom Intermediates
Chapter 5. Global Pharmaceutcials Intermediates (PI) Market, by End User
5.1. Pharmaceutical & Biotechnology Companies
5.2. Contract Manufacturing Organization
5.3. Research Laboratories
Chapter 6. Global Pharmaceutical Intermediates (PI) Market, by Geography
6.1. Overview
6.2. North America PI Market Analysis, 2017– 2027
6.2.1. North America PI Market, by Product, 2017 – 2027 (US$ Mn)
6.2.2. North America PI Market, by End User, 2017 – 2027 (US$ Mn)
6.2.3. North America PI Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe PI Market Analysis, 2017 – 2027
6.3.1. Europe PI Market, by Product, 2017– 2027 (US$ Mn)
6.3.2. Europe PI Market, by End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific PI Market Analysis, 2017 – 2027
6.4.1. Asia Pacific PI Market, by Product, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific PI Market, by End User, 2017– 2027 (US$ Mn)
6.4.3. Asia Pacific PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America PI Market Analysis, 2017 – 2027
6.5.1. Latin America PI Market, by Product, 2017 – 2027 (US$ Mn)
6.5.2. Latin America PI Market, by End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa PI Market Analysis, 2017 – 2027
6.6.1. MEA PI Market, by Product, 2017 – 2027 (US$ Mn)
6.6.2. MEA PI Market, by End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. BASF SE
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bristol Myers Squibb Company
7.3. Cambrex Corporation
7.4. Chiracon GmbH
7.5. Codexis, Inc.
7.6. Dishman Group
7.7. Dextra Laboratories, Ltd.
7.8. Lonza
7.9. Midas Pharma GmbH
7.10. Vertellus Holdings LLC
List of Figures
FIG. 1 Pharmaceutical Intermediates (PI) Market: Research Methodology
FIG. 2 PI: Market Segmentation
FIG. 3 Global PI Market, by Product, 2018 (US$ Mn)
FIG. 4 Global PI Market, by End User, 2018 (US$ Mn)
FIG. 5 Global PI Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global PI Market, by Key Players, 2018
FIG. 8 Global Bulk Drug PI Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Chemical PI Market, 2017– 2027 (US$ Mn)
FIG. 10 Global Custom PI Market, 2017 – 2027 (US$ Mn)
FIG. 11 Global Pharmaceutical & Biotechnology Companies Market for PI, 2017 – 2027 (US$ Mn)
FIG. 12 Global Contract Manufacturing Organization Market for PI, 2017 – 2027 (US$ Mn)
FIG. 13 Global Research Laboratories Market for PI, 2017 – 2027 (US$ Mn)
FIG. 14 U.S. PI Market, 2017 – 2027 (US$ Mn)
FIG. 15 Canada PI Market, 2017 – 2027 (US$ Mn)
FIG. 16 U.K. PI Market, 2017 – 2027 (US$ Mn)
FIG. 17 Germany PI Market, 2017– 2027 (US$ Mn)
FIG. 18 Rest of Europe PI Market, 2017 – 2027 (US$ Mn)
FIG. 19 China PI Market, 2017 – 2027 (US$ Mn)
FIG. 20 Japan PI Market, 2017 – 2027 (US$ Mn)
FIG. 21 Rest of Asia Pacific PI Market, 2017 – 2027 (US$ Mn)
FIG. 22 Brazil PI Market, 2017 – 2027 (US$ Mn)
FIG. 23 Mexico PI Market, 2017 – 2027 (US$ Mn)
FIG. 24 Rest of Latin America PI Market, 2017 – 2027 (US$ Mn)
FIG. 25 GCC PI Market, 2017 – 2027 (US$ Mn)
FIG. 26 Rest of MEA PI Market, 2017 – 2027 (US$ Mn)
List of Tables
TABLE 1 Global Pharmaceutical Intermediates (PI) Market Portraiture
TABLE 2 Global PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 3 Global PI Market , by End User, 2017 – 2027 (US$ Mn)
TABLE 4 Global PI Market, by Geography, 2017 – 2027(US$ Mn)
TABLE 5 North America PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 6 North America PI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 7 North America PI Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 9 Europe PI Market, by End User, 2017 – 2027(US$ Mn)
TABLE 10 Europe PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific PI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific PI Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 14 Latin America PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America PI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa PI Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa PI Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa PI Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 BASF SE: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bristol Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Cambrex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Chiracon GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Codexis, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Dishman Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Dextra Laboratories, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Lonza: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Midas Pharma GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vertellus Holdings LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)